BioSpace News Archive

Business

Photonic BioSystems Announces Out-Licensing Program for Microbiological Sensing and Liquid Handling Technologies

The technology was originally developed for Department of Defense field applications.

November 9, 2017
·
3 min read
Business

Signet Accel Appoints New Vice President of Marketing Amid Growth

Software and services company Signet Accel announced today that Carolyn Ewing-Turner joined the company as Vice President of Marketing.

November 9, 2017
·
3 min read
Drug Development

Promius Pharma Initiates Phase III Clinical Trials of DFD-03 for The Treatment of Acne Vulgaris

This short-contact formulation is expected to bring a new dimension to the treatment of acne patients.

November 9, 2017
·
2 min read
Pharm Country

Johnson & Johnson Vision Announces TearScience LipiScan and LipiFlow Now Available in More Than 800 Eye Care Practices to Image Meibomian Glands and Treat Meibomian Gland Dysfunction

Meibomian Gland Dysfunction (MGD) is a primary cause of dry eye disease, which impacts more than 340 million people globally.

November 9, 2017
·
3 min read
Business

FibroGen Reports Third Quarter 2017 Financial Results

FibroGen will host a conference call and webcast today, November 8, 2017, at 5:00 p.m. ET to discuss financial results and provide a business update.

November 9, 2017
·
11 min read
Business

Adverum Biotechnologies Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Cash, cash equivalents and marketable securities were $186.6 million as of September 30, 2017, compared to $197.4 million as of June 30, 2017 and $222.2 million as of December 31, 2016.

November 9, 2017
·
9 min read
Business

Achaogen Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Conference call today at 4:30 p.m. Eastern Time.

November 9, 2017
·
10 min read
Business

Otonomy Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Conference call and webcast today at 4:30 p.m. EST

November 9, 2017
·
12 min read
Business

Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results

Total revenue was $2.6 million for the three months ended September 30, 2017, compared to $12.5 million for the same period in 2016.

November 9, 2017
·
15 min read
Deals

Fuse Medical Signs Non-Binding Letter of Intent to Purchase all of the Outstanding Membership Units of CPM Medical Consultants, LLC

Although no binding obligation will be created until the execution of a definitive purchase agreement, the Company and the members of CPM are currently negotiating the definitive purchase agreement with a targeted fourth quarter close date.

November 9, 2017
·
3 min read